Cart
sales@molnova.com
Home - Products - Apoptosis - Apoptosis - Lanperisone HCl

Lanperisone HCl

CAS No. 116287-13-9

Lanperisone HCl( —— )

Catalog No. M36367 CAS No. 116287-13-9

Lanperisone HCl (NK 433) is a novel orally available centrally acting muscle relaxant with anticancer activity and inhibits mono- and polysynaptic reflex potentials.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 445 Get Quote
5MG 683 Get Quote
10MG 938 Get Quote
25MG 1371 Get Quote
50MG 1822 Get Quote
100MG 2475 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Lanperisone HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Lanperisone HCl (NK 433) is a novel orally available centrally acting muscle relaxant with anticancer activity and inhibits mono- and polysynaptic reflex potentials.
  • Description
    Lanperisone HCl (NK 433) is a novel orally available centrally acting muscle relaxant with anticancer activity and inhibits mono- and polysynaptic reflex potentials.Lanperisone HCl acts by inducing non-apoptotic cell death in the cell cycle and translational independence.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    116287-13-9
  • Formula Weight
    321.77
  • Molecular Formula
    C15H19ClF3NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C([C@@H](CN1CCCC1)C)(=O)C2=CC=C(C(F)(F)F)C=C2.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • 3BDO

    3BDO is a new mTOR activator. 3BDO inhibits autophagy.

  • EC359

    EC359 is a potent and selective inhibitor of leukemia inhibitory factor receptor (LIFR), a potent inhibitor with anticancer activity, blocks LIF/LIFR interaction, and can be used in the study of leukemia and endometrial cancer.

  • Bisindolylmaleimide ...

    Bisindolylmaleimide VIII acetate is a potent and selective PKC inhibitor (IC50: 158 nM for rat brain PKC).

Sign In Join Free